Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 12/20 | 0.56 |
| ▸ | PPARG | P37231 | 10/20 | 0.56 |
| ▸ | PPARD | Q03181 | 2/20 | 0.52 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | ICMT | O60725 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3866908 | 0.96 | PPARA (0.55) | PPARAPPARGPPARDGGPS1CTSB | |
| SCHEMBL13897395 | 0.96 | PPARA (0.55) | PPARAPPARGPPARDGGPS1CTSB | |
| SCHEMBL13897522 | 0.94 | PPARA (0.58) | PPARAPPARGPPARDGGPS1CTSB | |
| SCHEMBL3866049 | 0.94 | PPARA (0.58) | PPARAPPARGPPARDGGPS1CTSB | |
| SCHEMBL3863447 | 0.90 | PPARA (0.61) | PPARAPPARGPPARDCTSSCTSK | |
| SCHEMBL4817129 | 0.90 | PPARA (0.61) | PPARAPPARGPPARDCTSSCTSK | |
| SCHEMBL3863501 | 0.88 | PPARA (0.46) | PPARAPPARGPPARDGGPS1CTSS | |
| SCHEMBL3875723 | 0.88 | PPARG (0.46) | PPARAPPARGPPARDGGPS1CTSB | |
| SCHEMBL3863222 | 0.87 | PPARA (0.43) | PPARAPPARGPPARDGGPS1CTSB | |
| SCHEMBL13897480 | 0.87 | PPARA (0.43) | PPARAPPARGPPARDGGPS1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7498356-B2 | Substituted amino carboxylic acids | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) | 2009-03-03 | — | — | US | disclosed |
| US-7498356-B2 | Substituted amino carboxylic acids | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) | 2009-03-03 | — | — | US | disclosed |
| US-7498356-B2 | Substituted amino carboxylic acids | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) | 2009-03-03 | — | — | US | disclosed |
| US-20060122223-A1 | Substituted amino carboxylic acids | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC | 2006-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122223-A1 | Substituted amino carboxylic acids | PTPRS, PTPRO, PTPRJ | PPARA 314/4885PPARG 328/4885PPARD 741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.